{"registry_intelligence":{"schema_version":"alpha-registry-intelligence-v1","record_version":"unavailable","subject":"alpha:company:atea-pharmaceuticals-inc","as_of":"unavailable","recorded_at":"unavailable","availability":"unavailable","records":[],"next_offset":null,"limitations":["Structured intelligence is not currently available. Existing published profile evidence remains accessible."]},"protocol_version":"0.1","schema_version":"alpha.governance.entity.public.v1","record_version":"public-1","entity":{"id":"alpha:company:b7501c6c-b71e-410c-9417-edc16acc3e24","type":"Company","slug":"atea-pharmaceuticals-inc","canonical_url":"https://registry.alpha.ac/companies/atea-pharmaceuticals-inc","legal_name":"Atea Pharmaceuticals, Inc.","display_name":"Atea Pharmaceuticals, Inc.","aliases":[]},"publication":{"state":"PUBLISHED","published_at":"2026-09-30T04:46:21.537411+00:00","observed_at":"2026-09-30T04:46:21.537411+00:00","reviewed_at":"2026-09-30T04:46:21.537411+00:00","verified_at":"2026-09-30T04:46:21.537411+00:00"},"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":18,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed."},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"},"representations":{"html":{"href":"https://registry.alpha.ac/companies/atea-pharmaceuticals-inc","media_type":"text/html"},"markdown":{"href":"https://registry.alpha.ac/companies/atea-pharmaceuticals-inc.md","media_type":"text/markdown"},"json":{"href":"https://registry.alpha.ac/api/public/companies/atea-pharmaceuticals-inc?format=record","media_type":"application/json"},"jsonld":{"href":"https://registry.alpha.ac/api/public/companies/atea-pharmaceuticals-inc?format=jsonld","media_type":"application/ld+json"},"api":{"href":"https://registry.alpha.ac/api/public/companies/atea-pharmaceuticals-inc","media_type":"application/json"},"mcp":{"uri":"alpha://companies/atea-pharmaceuticals-inc","endpoint":"https://mcp.alpha.ac/mcp","media_type":"application/json"}},"limitations":["Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.","Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."],"aggregation":{"schema_version":"alpha-claim-aggregation-v1","published_claim_count":18,"under_review_claim_count":1,"owner_supplied_claim_count":0,"evidence_record_count":3,"distinct_source_count":3,"conflicts":[],"conflict_count":0,"headline_conflict_count":0,"internal_review_conflict_count":0,"contradiction_types":[],"headline_conflict_types":[],"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":18,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed."},"coverage":{"schema_version":"alpha-coverage-metric-v1","published_claims":18,"corroborated_claims":0,"sources":3,"distinct_sources":3,"role_claims":0,"last_reviewed_at":"2026-09-30T04:46:21.537411+00:00","observed_at":"2026-09-30T04:46:21.537411+00:00","freshness_days":0}},"claims":[{"id":"alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:legal_name:1","subject_id":"alpha:company:b7501c6c-b71e-410c-9417-edc16acc3e24","predicate":"schema:legalName","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Atea Pharmaceuticals, Inc.","claim_type":"legal_name","predicate_id":"alpha:predicate:legal_name","predicate_version":1,"machine_key":"legal_name","human_label":"Legal Name","governed_predicate":true,"machine_value":"Atea Pharmaceuticals, Inc.","corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-09-30T04:46:21.537411+00:00","sources":[{"id":"alpha:evidence:company:b7501c6c-b71e-410c-9417-edc16acc3e24:1","source_type":"canonical_identity","title":"Alpha canonical company public projection","publisher":"Alpha canonical company public projection","url":"https://www.alpha.ac/api/public/companies/atea-pharmaceuticals-inc","source_date":null,"retrieved_at":"2026-09-30T04:46:21.537411+00:00","locator":null}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-09-30T04:46:21.537411+00:00","reviewed_at":"2026-09-30T04:46:21.537411+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:entity_status:3","subject_id":"alpha:company:b7501c6c-b71e-410c-9417-edc16acc3e24","predicate":"alpha:entityStatus","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Public listing published","claim_type":"entity_status","predicate_id":"alpha:predicate:entity_status","predicate_version":1,"machine_key":"entity_status","human_label":"Entity Status","governed_predicate":true,"machine_value":"Public listing published","corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-09-30T04:46:21.537411+00:00","sources":[{"id":"alpha:evidence:company:b7501c6c-b71e-410c-9417-edc16acc3e24:1","source_type":"canonical_identity","title":"Alpha canonical company public projection","publisher":"Alpha canonical company public projection","url":"https://www.alpha.ac/api/public/companies/atea-pharmaceuticals-inc","source_date":null,"retrieved_at":"2026-09-30T04:46:21.537411+00:00","locator":null}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-09-30T04:46:21.537411+00:00","reviewed_at":"2026-09-30T04:46:21.537411+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:published_fact:4","subject_id":"alpha:company:b7501c6c-b71e-410c-9417-edc16acc3e24","predicate":"alpha:country","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"US","claim_type":"published_fact","predicate_id":"alpha:predicate:published_fact","predicate_version":1,"machine_key":"published_fact","human_label":"Published Fact","governed_predicate":true,"machine_value":"US","corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-09-30T04:46:21.537411+00:00","sources":[{"id":"alpha:evidence:company:b7501c6c-b71e-410c-9417-edc16acc3e24:1","source_type":"canonical_identity","title":"Alpha canonical company public projection","publisher":"Alpha canonical company public projection","url":"https://www.alpha.ac/api/public/companies/atea-pharmaceuticals-inc","source_date":null,"retrieved_at":"2026-09-30T04:46:21.537411+00:00","locator":null}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-09-30T04:46:21.537411+00:00","reviewed_at":"2026-09-30T04:46:21.537411+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:leadership_role:5","subject_id":"alpha:company:b7501c6c-b71e-410c-9417-edc16acc3e24","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:arthur-kirsch","object_label":null,"object_source_name_forms":[],"value":"Arthur Kirsch: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":"Arthur Kirsch: Director","corroboration_count":1,"source_claim_count":1,"valid_from":"2025-01-01","valid_to":null,"recorded_at":"2026-09-30T04:46:21.537411+00:00","sources":[{"id":"alpha:evidence:company:b7501c6c-b71e-410c-9417-edc16acc3e24:2","source_type":"sec_proxy","title":"Atea Pharmaceuticals, Inc. DEF 14A 2025-04-29","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1593899/000119312525104019/d931077ddef14a.htm","source_date":"2025-04-29","retrieved_at":"2026-04-24T16:20:01.187+00:00","locator":null}],"source_date":"2025-04-29","effective_from":"2025-01-01","effective_until":null,"observed_at":"2026-09-30T04:46:21.537411+00:00","reviewed_at":"2026-09-30T04:46:21.537411+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:leadership_role:6","subject_id":"alpha:company:b7501c6c-b71e-410c-9417-edc16acc3e24","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:barbara-duncan","object_label":null,"object_source_name_forms":[],"value":"Barbara Duncan: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":"Barbara Duncan: Director","corroboration_count":1,"source_claim_count":1,"valid_from":"2020-01-01","valid_to":null,"recorded_at":"2026-09-30T04:46:21.537411+00:00","sources":[{"id":"alpha:evidence:company:b7501c6c-b71e-410c-9417-edc16acc3e24:2","source_type":"sec_proxy","title":"Atea Pharmaceuticals, Inc. DEF 14A 2025-04-29","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1593899/000119312525104019/d931077ddef14a.htm","source_date":"2025-04-29","retrieved_at":"2026-04-24T16:20:01.187+00:00","locator":null}],"source_date":"2025-04-29","effective_from":"2020-01-01","effective_until":null,"observed_at":"2026-09-30T04:46:21.537411+00:00","reviewed_at":"2026-09-30T04:46:21.537411+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:leadership_role:7","subject_id":"alpha:company:b7501c6c-b71e-410c-9417-edc16acc3e24","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:bruce-w-polsky-md-macp-fidsa","object_label":null,"object_source_name_forms":[],"value":"Bruce W. Polsky, MD, MACP, FIDSA: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":"Bruce W. Polsky, MD, MACP, FIDSA: Director","corroboration_count":1,"source_claim_count":1,"valid_from":"2014-01-01","valid_to":null,"recorded_at":"2026-09-30T04:46:21.537411+00:00","sources":[{"id":"alpha:evidence:company:b7501c6c-b71e-410c-9417-edc16acc3e24:2","source_type":"sec_proxy","title":"Atea Pharmaceuticals, Inc. DEF 14A 2025-04-29","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1593899/000119312525104019/d931077ddef14a.htm","source_date":"2025-04-29","retrieved_at":"2026-04-24T16:20:01.187+00:00","locator":null}],"source_date":"2025-04-29","effective_from":"2014-01-01","effective_until":null,"observed_at":"2026-09-30T04:46:21.537411+00:00","reviewed_at":"2026-09-30T04:46:21.537411+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:leadership_role:8","subject_id":"alpha:company:b7501c6c-b71e-410c-9417-edc16acc3e24","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:bruno-lucidi","object_label":null,"object_source_name_forms":[],"value":"Bruno Lucidi: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":"Bruno Lucidi: Director","corroboration_count":1,"source_claim_count":1,"valid_from":"2014-01-01","valid_to":null,"recorded_at":"2026-09-30T04:46:21.537411+00:00","sources":[{"id":"alpha:evidence:company:b7501c6c-b71e-410c-9417-edc16acc3e24:2","source_type":"sec_proxy","title":"Atea Pharmaceuticals, Inc. DEF 14A 2025-04-29","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1593899/000119312525104019/d931077ddef14a.htm","source_date":"2025-04-29","retrieved_at":"2026-04-24T16:20:01.187+00:00","locator":null}],"source_date":"2025-04-29","effective_from":"2014-01-01","effective_until":null,"observed_at":"2026-09-30T04:46:21.537411+00:00","reviewed_at":"2026-09-30T04:46:21.537411+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:leadership_role:9","subject_id":"alpha:company:b7501c6c-b71e-410c-9417-edc16acc3e24","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:franklin-berger","object_label":null,"object_source_name_forms":[],"value":"Franklin Berger: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":"Franklin Berger: Director","corroboration_count":1,"source_claim_count":1,"valid_from":"2019-01-01","valid_to":null,"recorded_at":"2026-09-30T04:46:21.537411+00:00","sources":[{"id":"alpha:evidence:company:b7501c6c-b71e-410c-9417-edc16acc3e24:2","source_type":"sec_proxy","title":"Atea Pharmaceuticals, Inc. DEF 14A 2025-04-29","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1593899/000119312525104019/d931077ddef14a.htm","source_date":"2025-04-29","retrieved_at":"2026-04-24T16:20:01.187+00:00","locator":null}],"source_date":"2025-04-29","effective_from":"2019-01-01","effective_until":null,"observed_at":"2026-09-30T04:46:21.537411+00:00","reviewed_at":"2026-09-30T04:46:21.537411+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:leadership_role:10","subject_id":"alpha:company:b7501c6c-b71e-410c-9417-edc16acc3e24","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:howard-h-berman-phd","object_label":null,"object_source_name_forms":[],"value":"Howard H. Berman, PhD: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":"Howard H. Berman, PhD: Director","corroboration_count":1,"source_claim_count":1,"valid_from":"2025-01-01","valid_to":null,"recorded_at":"2026-09-30T04:46:21.537411+00:00","sources":[{"id":"alpha:evidence:company:b7501c6c-b71e-410c-9417-edc16acc3e24:2","source_type":"sec_proxy","title":"Atea Pharmaceuticals, Inc. DEF 14A 2025-04-29","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1593899/000119312525104019/d931077ddef14a.htm","source_date":"2025-04-29","retrieved_at":"2026-04-24T16:20:01.187+00:00","locator":null}],"source_date":"2025-04-29","effective_from":"2025-01-01","effective_until":null,"observed_at":"2026-09-30T04:46:21.537411+00:00","reviewed_at":"2026-09-30T04:46:21.537411+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:leadership_role:11","subject_id":"alpha:company:b7501c6c-b71e-410c-9417-edc16acc3e24","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:jean-pierre-sommadossi-phd","object_label":null,"object_source_name_forms":[],"value":"Jean-Pierre Sommadossi, PhD: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":"Jean-Pierre Sommadossi, PhD: Director","corroboration_count":1,"source_claim_count":1,"valid_from":"2014-01-01","valid_to":null,"recorded_at":"2026-09-30T04:46:21.537411+00:00","sources":[{"id":"alpha:evidence:company:b7501c6c-b71e-410c-9417-edc16acc3e24:2","source_type":"sec_proxy","title":"Atea Pharmaceuticals, Inc. DEF 14A 2025-04-29","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1593899/000119312525104019/d931077ddef14a.htm","source_date":"2025-04-29","retrieved_at":"2026-04-24T16:20:01.187+00:00","locator":null}],"source_date":"2025-04-29","effective_from":"2014-01-01","effective_until":null,"observed_at":"2026-09-30T04:46:21.537411+00:00","reviewed_at":"2026-09-30T04:46:21.537411+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:leadership_role:12","subject_id":"alpha:company:b7501c6c-b71e-410c-9417-edc16acc3e24","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:jerome-adams-md-mph","object_label":null,"object_source_name_forms":[],"value":"Jerome Adams, MD, MPH: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":"Jerome Adams, MD, MPH: Director","corroboration_count":1,"source_claim_count":1,"valid_from":"2021-01-01","valid_to":null,"recorded_at":"2026-09-30T04:46:21.537411+00:00","sources":[{"id":"alpha:evidence:company:b7501c6c-b71e-410c-9417-edc16acc3e24:2","source_type":"sec_proxy","title":"Atea Pharmaceuticals, Inc. DEF 14A 2025-04-29","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1593899/000119312525104019/d931077ddef14a.htm","source_date":"2025-04-29","retrieved_at":"2026-04-24T16:20:01.187+00:00","locator":null}],"source_date":"2025-04-29","effective_from":"2021-01-01","effective_until":null,"observed_at":"2026-09-30T04:46:21.537411+00:00","reviewed_at":"2026-09-30T04:46:21.537411+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:leadership_role:13","subject_id":"alpha:company:b7501c6c-b71e-410c-9417-edc16acc3e24","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:polly-a-murphy-dvm-phd","object_label":null,"object_source_name_forms":[],"value":"Polly A. Murphy, DVM, PhD: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":"Polly A. Murphy, DVM, PhD: Director","corroboration_count":1,"source_claim_count":1,"valid_from":"2020-01-01","valid_to":null,"recorded_at":"2026-09-30T04:46:21.537411+00:00","sources":[{"id":"alpha:evidence:company:b7501c6c-b71e-410c-9417-edc16acc3e24:2","source_type":"sec_proxy","title":"Atea Pharmaceuticals, Inc. DEF 14A 2025-04-29","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1593899/000119312525104019/d931077ddef14a.htm","source_date":"2025-04-29","retrieved_at":"2026-04-24T16:20:01.187+00:00","locator":null}],"source_date":"2025-04-29","effective_from":"2020-01-01","effective_until":null,"observed_at":"2026-09-30T04:46:21.537411+00:00","reviewed_at":"2026-09-30T04:46:21.537411+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:leadership_role:14","subject_id":"alpha:company:b7501c6c-b71e-410c-9417-edc16acc3e24","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:andrea-corcoran-avir","object_label":null,"object_source_name_forms":[],"value":"Andrea Corcoran: Chief Financial Officer, Executive Vice President, Legal and Secretary","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":"Andrea Corcoran: Chief Financial Officer, Executive Vice President, Legal and Secretary","corroboration_count":1,"source_claim_count":1,"valid_from":"2026-03-05","valid_to":null,"recorded_at":"2026-09-30T04:46:21.537411+00:00","sources":[{"id":"alpha:evidence:company:b7501c6c-b71e-410c-9417-edc16acc3e24:3","source_type":"sec_filing","title":"AVIR 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1593899/000119312526094159/avir-20251231.htm","source_date":"2026-03-05T00:00:00+00:00","retrieved_at":"2026-05-14T23:47:32.693955+00:00","locator":null}],"source_date":"2026-03-05T00:00:00+00:00","effective_from":"2026-03-05","effective_until":null,"observed_at":"2026-09-30T04:46:21.537411+00:00","reviewed_at":"2026-09-30T04:46:21.537411+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:leadership_role:15","subject_id":"alpha:company:b7501c6c-b71e-410c-9417-edc16acc3e24","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:janet-hammond-m-d-ph-d-avir","object_label":null,"object_source_name_forms":[],"value":"Janet Hammond, M.D., Ph.D.: Chief Development Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":"Janet Hammond, M.D., Ph.D.: Chief Development Officer","corroboration_count":1,"source_claim_count":1,"valid_from":"2026-03-05","valid_to":null,"recorded_at":"2026-09-30T04:46:21.537411+00:00","sources":[{"id":"alpha:evidence:company:b7501c6c-b71e-410c-9417-edc16acc3e24:3","source_type":"sec_filing","title":"AVIR 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1593899/000119312526094159/avir-20251231.htm","source_date":"2026-03-05T00:00:00+00:00","retrieved_at":"2026-05-14T23:47:32.693955+00:00","locator":null}],"source_date":"2026-03-05T00:00:00+00:00","effective_from":"2026-03-05","effective_until":null,"observed_at":"2026-09-30T04:46:21.537411+00:00","reviewed_at":"2026-09-30T04:46:21.537411+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:leadership_role:16","subject_id":"alpha:company:b7501c6c-b71e-410c-9417-edc16acc3e24","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:jean-pierre-sommadossi-ph-d-avir","object_label":null,"object_source_name_forms":[],"value":"Jean-Pierre Sommadossi, Ph.D.: President and Chief Executive Officer and Chairman of the Board of Directors","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":"Jean-Pierre Sommadossi, Ph.D.: President and Chief Executive Officer and Chairman of the Board of Directors","corroboration_count":1,"source_claim_count":1,"valid_from":"2026-03-05","valid_to":null,"recorded_at":"2026-09-30T04:46:21.537411+00:00","sources":[{"id":"alpha:evidence:company:b7501c6c-b71e-410c-9417-edc16acc3e24:3","source_type":"sec_filing","title":"AVIR 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1593899/000119312526094159/avir-20251231.htm","source_date":"2026-03-05T00:00:00+00:00","retrieved_at":"2026-05-14T23:47:32.693955+00:00","locator":null}],"source_date":"2026-03-05T00:00:00+00:00","effective_from":"2026-03-05","effective_until":null,"observed_at":"2026-09-30T04:46:21.537411+00:00","reviewed_at":"2026-09-30T04:46:21.537411+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:leadership_role:17","subject_id":"alpha:company:b7501c6c-b71e-410c-9417-edc16acc3e24","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:john-vavricka-avir","object_label":null,"object_source_name_forms":[],"value":"John Vavricka: Chief Commercial Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":"John Vavricka: Chief Commercial Officer","corroboration_count":1,"source_claim_count":1,"valid_from":"2026-03-05","valid_to":null,"recorded_at":"2026-09-30T04:46:21.537411+00:00","sources":[{"id":"alpha:evidence:company:b7501c6c-b71e-410c-9417-edc16acc3e24:3","source_type":"sec_filing","title":"AVIR 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1593899/000119312526094159/avir-20251231.htm","source_date":"2026-03-05T00:00:00+00:00","retrieved_at":"2026-05-14T23:47:32.693955+00:00","locator":null}],"source_date":"2026-03-05T00:00:00+00:00","effective_from":"2026-03-05","effective_until":null,"observed_at":"2026-09-30T04:46:21.537411+00:00","reviewed_at":"2026-09-30T04:46:21.537411+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:leadership_role:18","subject_id":"alpha:company:b7501c6c-b71e-410c-9417-edc16acc3e24","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:maria-arantxa-horga-m-d-avir","object_label":null,"object_source_name_forms":[],"value":"Maria Arantxa Horga, M.D.: Chief Medical Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":"Maria Arantxa Horga, M.D.: Chief Medical Officer","corroboration_count":1,"source_claim_count":1,"valid_from":"2026-03-05","valid_to":null,"recorded_at":"2026-09-30T04:46:21.537411+00:00","sources":[{"id":"alpha:evidence:company:b7501c6c-b71e-410c-9417-edc16acc3e24:3","source_type":"sec_filing","title":"AVIR 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1593899/000119312526094159/avir-20251231.htm","source_date":"2026-03-05T00:00:00+00:00","retrieved_at":"2026-05-14T23:47:32.693955+00:00","locator":null}],"source_date":"2026-03-05T00:00:00+00:00","effective_from":"2026-03-05","effective_until":null,"observed_at":"2026-09-30T04:46:21.537411+00:00","reviewed_at":"2026-09-30T04:46:21.537411+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"},{"id":"alpha:claim:company:b7501c6c-b71e-410c-9417-edc16acc3e24:leadership_role:19","subject_id":"alpha:company:b7501c6c-b71e-410c-9417-edc16acc3e24","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:wayne-foster-avir","object_label":null,"object_source_name_forms":[],"value":"Wayne Foster: Executive Vice President and Chief Accounting Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":"Wayne Foster: Executive Vice President and Chief Accounting Officer","corroboration_count":1,"source_claim_count":1,"valid_from":"2026-03-05","valid_to":null,"recorded_at":"2026-09-30T04:46:21.537411+00:00","sources":[{"id":"alpha:evidence:company:b7501c6c-b71e-410c-9417-edc16acc3e24:3","source_type":"sec_filing","title":"AVIR 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1593899/000119312526094159/avir-20251231.htm","source_date":"2026-03-05T00:00:00+00:00","retrieved_at":"2026-05-14T23:47:32.693955+00:00","locator":null}],"source_date":"2026-03-05T00:00:00+00:00","effective_from":"2026-03-05","effective_until":null,"observed_at":"2026-09-30T04:46:21.537411+00:00","reviewed_at":"2026-09-30T04:46:21.537411+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1"}],"evidence":[{"id":"alpha:evidence:company:b7501c6c-b71e-410c-9417-edc16acc3e24:1","source_type":"canonical_identity","title":"Alpha canonical company public projection","publisher":"Alpha canonical company public projection","url":"https://www.alpha.ac/api/public/companies/atea-pharmaceuticals-inc","source_date":null,"retrieved_at":"2026-09-30T04:46:21.537411+00:00","locator":null},{"id":"alpha:evidence:company:b7501c6c-b71e-410c-9417-edc16acc3e24:2","source_type":"sec_proxy","title":"Atea Pharmaceuticals, Inc. DEF 14A 2025-04-29","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1593899/000119312525104019/d931077ddef14a.htm","source_date":"2025-04-29","retrieved_at":"2026-04-24T16:20:01.187+00:00","locator":null},{"id":"alpha:evidence:company:b7501c6c-b71e-410c-9417-edc16acc3e24:3","source_type":"sec_filing","title":"AVIR 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1593899/000119312526094159/avir-20251231.htm","source_date":"2026-03-05T00:00:00+00:00","retrieved_at":"2026-05-14T23:47:32.693955+00:00","locator":null}],"coverage":{"identity":"PUBLISHED","business":"PUBLISHED","leadership":"PUBLISHED","board_and_committees":"PUBLISHED","governance":"NOT_ASSERTED","financials":"NOT_ASSERTED","workforce":"NOT_ASSERTED","ownership":"NOT_ASSERTED","ratings":"NOT_PUBLISHED","market_and_index_context":"PUBLISHED"},"representation_version":"alpha-governance-record-v2","role_modules":[],"attention":[],"committee_data":[]}